English
Deutsch
Français
Nederlands
Español
Reset. Heal. Grow.
When Chronic Illness Breaks You: Finding Real Healing Beyond the Hyper-Vigilance
There's a specific exhaustion that comes from living inside a body you can't fully trust. People who've spent decades managing a chronic condition know it well — the low hum of vigilance that never really switches off, the way your shoulders sit half an inch higher than everyone else's, the running mental checklist that keeps you tethered to the next possible threat. It looks a lot like anxiety from the outside. Underneath, it's something older and stranger. It's the nervous system deciding, quite reasonably, that the world is not safe. I've spent a lot of time in retreat spaces sitting next to people who arrived carrying exactly this. Severe allergies. Autoimmune conditions. Long COVID. Chronic pain that no scan could explain. What they had in common wasn't the diagnosis — it was the pattern that grew up around the diagnosis. A pattern that, in many cases, was doing more damage than the original illness by the time they showed up looking for help. This post is for people living inside that pattern, or loving someone who is. I want to talk honestly about how chronic illness rewires the nervous system, why traditional talk therapy sometimes stalls on it, and where practices like meditation, community, and — yes — plant medicine can actually move the needle. No promises. No hype. Just what I've seen and what the science increasingly supports. Most people underestimate how much cognitive real estate a chronic condition eats up. If you've grown up scanning restaurants for allergens, reading every label twice, mentally locating exits in unfamiliar rooms — that scanning becomes the substrate of your daily consciousness. It's not something you do. It's who you are. And when the reactions are severe enough to be life-threatening, a whole other layer settles in: the awareness that any lapse could be your last. Clinicians increasingly recognise this as a form of post-traumatic stress. It doesn't require a single defining event. It builds from the drip-feed of near-misses, ER trips, and the small daily humiliations of being the person who has to make everyone stop and read the menu again. One woman I met on a psilocybin retreat in the Netherlands described it perfectly: “I've been performing calm for so long, I forgot my body was allowed to relax.” The knock-on effects are predictable and brutal. Sleep goes first. Then appetite, or the ability to trust food at all. Social life contracts. Some people develop full-blown agoraphobia; others just quietly stop saying yes to things. And because the underlying illness is real — the allergen really can kill you, the pain really is unpredictable — the vigilance never feels irrational. That's what makes it so hard to unwind. Talk therapy helps. So do SSRIs, for some people. Cognitive behavioural approaches can chip away at the more obvious catastrophising loops. But for a lot of chronic-illness patients I've spoken with, these tools only get them so far. The problem isn't primarily cognitive. You can know, intellectually, that the restaurant is safe. Your body still won't let you eat. This is where the newer wave of somatic and psychedelic-assisted approaches comes in. The nervous system that's been in threat mode for twenty years needs more than a reframe — it needs a felt experience of safety, sustained long enough that something below the neck starts to believe it. That's a very specific kind of work. None of these are magic bullets. All of them require time, decent guidance, and a willingness to be uncomfortable. But when they work, they work at a depth that talk alone rarely reaches. Let me be careful here, because this is where a lot of nonsense gets written. Plant medicines — ayahuasca, psilocybin, San Pedro, ibogaine — are not treatments for allergies, autoimmune conditions, or any physical illness. Anyone telling you otherwise is either uninformed or selling something. What plant medicine can sometimes address is the psychological and nervous-system fallout that grows around a chronic condition: the trauma, the hyper-vigilance, the disordered relationship with your own body. The mechanism, as best current research understands it, involves a temporary increase in neuroplasticity — the brain's ability to form new connections and, crucially, to consider new interpretations of old experiences. During an ayahuasca ceremony, someone who's spent decades braced against their body might, for the first time in memory, feel their body as a home rather than a threat. Not because the illness has gone anywhere. Because the relationship to the illness has shifted. I've watched this happen. A man in his fifties, career derailed by chronic pain, spending most of a psilocybin retreat weeping quietly and then telling the circle on the last morning that he'd forgotten his body could feel anything other than an enemy. Whether that shift holds depends almost entirely on what he does in the six months after — the integration work, the community, the daily practices. The ceremony cracks the door. Walking through it is a longer job. If you're living with a chronic condition and considering a plant-medicine retreat, the vetting process needs to be more rigorous than it would be for someone in robust health. This is not a place to cut corners. A few things to look for: You'll notice these questions are basic. That's the point. If a retreat can't answer them clearly and without defensiveness, they're not the right fit — not because they're necessarily unsafe, but because you specifically need more than they're offering. Here's the thing nobody wants to hear: the retreat is the easy part. The hard part is the year afterwards, when the insights are supposed to translate into changed behaviour and mostly don't, unless you build the scaffolding for them to land on. Community shows up again and again as the most consistent predictor of who actually rebuilds their life after a difficult experience — chronic illness, addiction, trauma, take your pick. Not community in the vague inspirational sense. Specific people who understand what you've been through and don't need you to explain the baseline. For someone with severe allergies, that might be one friend who has the same condition and gets it without translation. For someone recovering from addiction, it might be a sponsor and a room full of people in the same boat. The people I've seen make the deepest changes tend to combine three things: a serious psychedelic or contemplative experience, ongoing daily practice (meditation, movement, breathwork — pick your medicine), and a small circle of people who can hold them accountable and witness the change. Take away any one leg and the stool tends to wobble. Most of the people I've met who've genuinely healed from the psychological weight of a chronic condition arrived at the same unglamorous conclusion. They stopped fighting the fact of the illness. Not resignation — something more active. A decision to build a life around the reality of the body they have, rather than the body they wish they had. Plant medicine can accelerate that recognition. So can years of therapy, or a good meditation practice, or a truly difficult conversation with someone who loves you. There's no single right doorway. There's just the doorway that opens for you, when it opens, and the work of walking through it. If any of this resonates and you're weighing whether a plant-medicine retreat might be part of your own path, curated ayahuasca, psilocybin, and plant-medicine retreats can be browsed on our marketplace here. Take your time with the decision. The right retreat, at the right moment, with the right preparation, is worth waiting for.
Should You Tell Your Therapist About Your Psychedelic Use? An Honest Guide
You've booked a new therapist. Maybe you're seeing them for depression, addiction, a tangle of trauma that keeps rerouting your life. And somewhere in your recent history — last month, last weekend, or a retreat you're already planning — there's an ayahuasca ceremony, a mushroom journey, or a microdosing routine you've been quietly running. Now you're sitting in the waiting room wondering: do I tell them? It's one of the most common questions in the psychedelic space right now, and the answers are messier than either side wants to admit. Full disclosure can get you dropped as a client or, in rare cases, reported. Total silence can hollow out the therapeutic relationship until it stops working. Somewhere in between is the honest, slightly uncomfortable truth — and figuring out where you land on that spectrum takes more than a Reddit thread. Let's walk through it properly. Twenty years ago it would've been an easy call: don't say a word. Psychedelics were a career-ending confession in most clinical rooms, and therapists were trained to treat any mention of them as a red flag for substance-use pathology. That world hasn't fully disappeared. But it's cracking. Ketamine clinics operate in most major cities. Psilocybin is legal for supervised use in Oregon and Colorado. MDMA-assisted therapy sits in front of the FDA. Universities are running trials on ayahuasca for treatment-resistant depression. Ibogaine is being studied for opioid dependence. The cultural gap between “I did mushrooms last summer” and “I take an SSRI” has narrowed dramatically — but your specific therapist may or may not have caught up. That's the whole tension in one sentence. The field has moved. Individual clinicians have moved at wildly different speeds. And you have no way of knowing where yours sits until you either ask or take the risk. Short-term, probably nothing. Therapy proceeds. You talk about your week, your relationships, your mother. The ceremony you did in Peru three months ago sits in a folder marked omit. The problem is that plant medicine and psychedelic experiences don't stay in folders. They leak. A mushroom journey that cracked open a memory of your father is going to shape what comes up in session for months — sometimes years. If your therapist doesn't know the source, they're working with half the map. They'll interpret the sudden emotional intensity, the new dreams, the strange somatic openings, as though they emerged from nowhere. You'll both be trying to solve a puzzle with pieces missing. The other thing that quietly happens: you learn to compartmentalize in the one room where you're paying not to. Therapy works partly because it's a place where you don't have to manage the other person's reaction. If you're carefully editing yourself around your psychedelic use, you're doing the exact thing therapy is supposed to dissolve. That's a real cost, even if you never quite notice it. Here's the range of responses you might get, roughly from best to worst: Most people are somewhere in the top three. The horror stories exist, but they're not the norm anymore. Here's the move most experienced psychedelic-integration folks recommend: don't lead with disclosure. Lead with a screening question. In your first or second session, work in something like: “I'm curious about your general stance on psychedelics and plant medicine — is that something you have experience working with clinically?” You're not admitting anything. You're gathering data. Their answer will tell you almost everything you need to know. If they light up and describe training in psychedelic-assisted therapy, you've hit gold. If they say something measured like “I don't have specific training but I'm open to discussing whatever's meaningful to you,” you can probably disclose safely. If they get stiff, quote the DEA, or immediately pivot to substance abuse questions, you've learned something important without exposing yourself. The one caveat: mandated reporting. In the U.S., therapists are required to report imminent harm to self or others and (in some states) certain categories of abuse. Recreational or ceremonial psychedelic use is not, by itself, a reportable condition anywhere I'm aware of. Driving your kids around while intoxicated is. Active suicidal planning during a difficult integration is. Know the difference. If you're planning a retreat — or you've just come home from one and the integration is heavier than you expected — it's worth looking specifically for a psychedelic-integration therapist rather than trying to retrofit a general clinician. They exist in most major cities and many work remotely. Things to look for: If cost is a barrier, look into peer integration circles. They're not therapy, but they can carry a lot of weight between sessions and often cost nothing. Slightly different question. If you're preparing for ayahuasca, ibogaine, or a psilocybin retreat and you're already in therapy, telling your therapist in advance is usually the right call — even if they can't formally endorse it. They can help you look honestly at your motivations. They can flag genuine contraindications, especially around SSRIs, MAOIs, lithium, and certain heart conditions. They can help you build a support scaffold for the weeks after you return, which is when most of the real work happens. And they can be a steady presence during integration, when everything you thought you knew about yourself is being rearranged in slow motion. A therapist who refuses to have this conversation at all — not “I can't advise you to do this,” which is fair, but “I won't discuss this with you” — is telling you something important about the ceiling of your work together. Disclosure isn't a binary. It's a judgment call you make with imperfect information about a specific person in a specific legal context. Ask before you tell. Notice how they respond to adjacent topics. Trust your read of the room — the same instincts that told you to try plant medicine in the first place are worth listening to here. And if you're in the earlier stage of all this — still deciding whether a ceremony is even the right move, still weighing the retreat options and the aftercare and the honest cost — the integration question isn't premature. It's part of the decision. For readers wanting to see what responsible plant-medicine programs actually look like on the ground, a range of vetted ayahuasca and psychedelic retreats can be browsed on our marketplace here. Whatever you decide about telling your therapist, decide it on purpose. That's the whole point of doing this work at all.
Sobriety and Plant Medicine: Rebuilding After Quitting Alcohol
The first ninety days without alcohol are strange. Not bad, exactly. Just strange. You sleep harder than you have in years, wake up early with a clarity that borders on uncomfortable, and start noticing things — the low hum of anxiety you'd been drowning, the resentment you'd been softening, the grief you'd been diluting one glass at a time. People talk about sobriety like it's the finish line. It isn't. It's the moment the actual work becomes visible. Which is why more and more people who've quit drinking end up quietly Googling something like ayahuasca for addiction or psilocybin retreats for sobriety. Not because they want to swap one substance for another — most are terrified of that — but because they suspect there's something underneath the drinking that never got addressed. And they're usually right. Alcohol is a coping mechanism dressed up as a social lubricant. Take it away and the coping doesn't vanish — it just loses its favourite tool. This is why so many people white-knuckle their way to six months sober and then find themselves depressed, restless, or drawn to some new fixation. Work. Food. Scrolling. A new relationship that feels suspiciously urgent. The nervous system that reached for a drink at 6pm every day was reaching for a reason. Sometimes the reason is trauma. Sometimes it's chronic low-grade depression. Sometimes it's a life that quietly stopped fitting years ago and you never wanted to face it sober. Traditional recovery programs are wonderful at community and structure, but they don't always get near the root. That's where a lot of people start looking sideways at plant medicine. The short answer is: the evidence is stronger than most people realise, and more limited than the enthusiasts claim. Somewhere in the middle is the honest picture. Johns Hopkins ran a psilocybin trial for alcohol use disorder that produced results serious enough to make even conservative addiction researchers pay attention — roughly a doubling of the reduction in heavy drinking days compared to placebo. Ibogaine, a West African root, has been used for decades in Mexico and other jurisdictions to interrupt opioid dependence, with unusual efficacy at breaking physical withdrawal. Ayahuasca, though harder to study because ceremonies vary so widely, keeps producing the same anecdotal pattern: people arrive with a decades-long drinking or drug habit and leave with the compulsion noticeably quieter, sometimes gone. None of this is a magic wand. Anyone who tells you otherwise is either selling something or hasn't seen enough people go through it. What plant medicine seems to do, when it works, is loosen the grip of the story that keeps the addiction alive. You suddenly see, very clearly, what you've been running from. Whether the change lasts depends almost entirely on what you do in the months afterwards. Ayahuasca gets most of the headlines, but in the Amazonian tradition it's part of a larger family of what curanderos call master plants — plant teachers with distinct personalities that work on different aspects of a person. Chacruna, chiric sanango, ajo sacha, bobinsana, tobacco (yes, real tobacco, used in radically different ways than we use it in the West). A serious dieta with any of these is nothing like a weekend retreat. It's weeks of isolation, restricted food, no salt, no sugar, no sex, no reading — just you and the plant. Most Westerners never do a full dieta. They come for a five or seven night ayahuasca retreat, drink the brew three or four times, and go home. That's a legitimate entry point, but it's worth understanding you're getting a taste of a much deeper tradition. The ceremony itself — the mareacion, the icaros the shaman sings, the purging, the visions — is the part that gets described in memoirs. The quieter, longer work of integrating what you saw is the part that actually matters for someone in recovery. Here's where I'll be blunt, because this decision deserves it. If you've been sober less than six months, most reputable facilitators will ask you to wait. Not because ayahuasca or psilocybin will make you relapse — usually the opposite — but because early sobriety is fragile in ways you may not fully appreciate yet. A powerful psychedelic experience while your nervous system is still recalibrating can be destabilising. Give yourself a foundation first. When you are ready, here's what actually matters when choosing a retreat: Cost varies wildly. A week-long ayahuasca retreat in Peru typically runs anywhere from around $1,200 at a rustic centre to $4,000+ at a well-staffed facility with medical support. Ibogaine treatment, because of the medical monitoring required, runs higher — often $6,000 to $10,000 for a week. Psilocybin retreats in legal jurisdictions like the Netherlands or Jamaica sit somewhere in between. The retreat is not the healing. This is the sentence I wish someone had tattooed onto my forearm before my first ceremony. The retreat is a doorway. What you do in the weeks and months after — how you sleep, who you talk to, what you stop doing, what you start doing — is the actual medicine. People who do well after plant medicine tend to build a boring, unglamorous scaffolding around the experience. They keep therapy going. They journal, even badly. They stay off alcohol for at least a good stretch afterwards (many find they don't want it anyway). They find one other person who's been through something similar and can talk to them honestly. They resist the urge to immediately book the next retreat, because chasing the peak experience is its own kind of drinking. People who don't do well tend to treat the ceremony as the answer and then wonder why, six months later, the old patterns are creeping back. The plants show you things. They don't do the work of changing you. You do that, slowly, in the ordinary Tuesday afternoons that follow. If you've stopped drinking recently and you're reading this, take the win first. That's not a small thing. Whatever pulled you into that habit had its reasons, and whatever pulled you out of it took real courage. Plant medicine may or may not be part of your next chapter. It's one path, not the path. Some people rebuild through therapy, community, running, prayer, a dog, a garden, a change of city. All valid. But if the pull toward exploring ayahuasca, psilocybin, or another plant medicine keeps returning — quietly, persistently, over months — it's worth listening to. Do the research. Talk to people who've actually been. Find a facilitator whose approach makes you feel safer, not more excited. For readers who want to take that next step, a range of vetted ayahuasca and psychedelic retreats can be browsed on our marketplace here, with details on facilitators, medical protocols, and integration support so you can compare properly before committing. Sobriety cracks something open. Whether you fill that space with medicine, meditation, or plain old time — fill it deliberately.
Can't Stop Ruminating? Why Plant Medicine Keeps Coming Up in the Conversation
Three in the morning. Same argument playing in your head from six years ago. You know it doesn't matter. You know the person barely remembers it. And still, your brain runs the tape, frame by frame, like it's looking for a different ending. If that sounds familiar, welcome to rumination — the mental loop that turns bedtime into a courtroom and quiet moments into interrogations. It's one of the most common complaints I hear from people considering an ayahuasca retreat or a psilocybin sit. Not depression exactly. Not trauma with a capital T. Just a mind that won't shut up. Standard advice says meditate, journal, exercise, talk to someone. All of it helps. But there's a subset of people for whom the usual toolkit only takes the edge off, and they start asking harder questions. Can psychedelics help with this? Are master plants actually good for stuck thinking? What does an ayahuasca ceremony do to a ruminating brain? Let's get into it honestly. Rumination isn't a character flaw. Neuroscientists tend to blame the default mode network — the constellation of brain regions that fires up when you're not focused on a task. It's the seat of self-referential thinking, autobiographical memory, and, unfortunately, worry. In depressed and anxious brains, this network gets stuck in overdrive. The volume knob is broken. Traditional mindfulness works by giving that network something else to do. You focus on the breath, the body, a candle, a mantra — and slowly the loops loosen their grip. It's genuinely effective. Long-term meditators show measurable changes in exactly the brain regions that go haywire in chronic rumination. The catch: it takes time. Months, often years. And if the underlying loop is fed by unprocessed grief, addiction, or trauma, meditation alone can feel like bailing out a boat with a teacup. This is where a lot of people start looking at plant medicine. Here's the interesting bit. Brain-imaging studies — the ones out of Imperial College London have been the most cited — show that psilocybin and ayahuasca temporarily quiet the default mode network. That same network that keeps replaying your worst moments? It goes offline. Briefly. And in that pause, something shifts. People come out of a psilocybin session or an ayahuasca ceremony describing the same thing over and over: the loop stopped. Not forever. But long enough for them to see it from the outside, notice it wasn't them, and get some leverage on it. Researchers call this ego dissolution or psychological flexibility. Participants usually just say something like, “I finally got some space from my own head.” This isn't hype. Clinical trials for psilocybin-assisted therapy in treatment-resistant depression have shown response rates that would embarrass most conventional medications. Ayahuasca studies from Brazil and Spain point in the same direction for people who've been stuck for years. The plant medicines don't erase the pain — they seem to make it workable again. Amazonian tradition frames ayahuasca, tobacco, San Pedro, and a handful of others as master plants — plantas maestras. The idea is that each plant has something to teach, and the ceremony is less like taking a drug and more like sitting with a difficult mentor for eight hours. Take that framing however you want. What matters practically is that people leave these ceremonies with insights, not just experiences. Someone who ruminates about a failed relationship might spend the night not reliving it, but seeing it from angles they never allowed themselves. A person locked in shame about an addiction might feel, for the first time in a decade, that they're worth forgiving. Whether you call that neurochemistry, spirit, or subconscious housekeeping, the outcome is the same — the loop weakens. A few master plants that come up most in this context: Different plants, different textures. None of them are magic. All of them ask something of you. Honest answer: sometimes yes, sometimes no. Here's how I'd think about it if I were the one making the decision. A retreat probably makes sense if you've tried the standard approaches — therapy, meditation, medication, lifestyle changes — with real effort over real time, and you're still stuck. If your rumination is tied to something specific (a loss, an addiction, an event) and you sense there's material underneath that you haven't been able to touch, plant medicine can be a genuine catalyst. And if you're the kind of person who can sit with intensity, follow instructions, and take integration seriously, you're a reasonable candidate. A retreat probably isn't the right move if you're in acute crisis, on SSRIs or MAOIs (a real medical concern with ayahuasca), have a family history of psychosis or bipolar disorder, or if you're hoping the ceremony will do the work so you don't have to. It won't. The plants show you the room. You still have to clean it. Cost is a real factor too. A legitimate ayahuasca retreat in Peru runs anywhere from around $1,200 for a shorter stay to $3,500+ for a well-run ten-day program. Ibogaine treatment in Mexico, because of the medical supervision required, tends to sit between $6,000 and $10,000. Add flights, time off work, and preparation. It's not a casual purchase. The space has grown fast, and not everyone hanging a shingle knows what they're doing. Some practical filters I'd apply before sending a deposit: Here's the part that rarely makes it into the brochure. The ceremony is maybe 20% of the work. The other 80% is what you do in the weeks and months afterward — the therapy, the journaling, the slow behavior changes, the conversations you finally have. People who treat a retreat as a one-and-done fix usually find their rumination back in the door within a season. People who treat it as a starting point often report that the loops genuinely quiet down for good. Practical integration looks unglamorous. Talking to a therapist who understands psychedelic experiences. Building a sitting practice you can actually sustain (ten minutes a day beats forty minutes twice a week). Sleep. Sunlight. Real food. Fewer screens. Difficult conversations you've been avoiding. Boring, obvious, effective. If you've read this far, some part of you is already leaning in. That's worth honoring, and also worth slowing down. Talk to a doctor if you're on any medication. Talk to a therapist if you can. Read first-hand accounts, especially the difficult ones. Give yourself a few months to decide rather than a few days. Rumination is a signal, not a defect. Your mind is telling you something needs attention. Sometimes that attention comes through meditation, sometimes through therapy, sometimes through a night in a candlelit maloca with a plant that tastes like tar and a shaman singing icaros until sunrise. Different roads, same direction — a mind with a little more room in it. If something in this piece has been sitting with you, a range of curated ayahuasca and plant-medicine retreats can be browsed on our marketplace here. Take your time, ask good questions, and choose deliberately. The loop in your head has been waiting years — a few more weeks of research won't hurt it.
When a Chronic Diagnosis Becomes a Doorway: Lessons From Living With Crohn's
The doctor called on a Tuesday afternoon with the biopsy results, and I laughed. Actually laughed. He'd just told me I had a disease I would carry for the rest of my life, and my body responded with something close to relief. The word was Crohn's. I had no clue what it meant. But after months of unexplained pain, hearing a name — any name — felt like someone had finally flipped on the light in a room I'd been stumbling around in for the better part of a year. To understand why relief was the first emotion, you have to know what came before it. And what came before it was a whole lot of being told I was fine when I very clearly wasn't. It started with a sharp pain low on the right side of my abdomen. Appendicitis runs in the family, so that was my working theory. The first doctor disagreed. He looked at me across the desk and asked, in that gentle voice physicians use when they've already decided, whether I was under a lot of pressure lately. I was, honestly. A handful of things had gone sideways in my life at once and I felt like I was being hit from every direction. So I said yes. He nodded like that solved it and suggested I take some time off. Travel a bit. Relax. So I did — three months of travel, actually — and the pain came right along with me, packed neatly in my carry-on. Second doctor: same verdict. Stress. Exercise more. Rest more. Work less. I did all of it. I still woke up at three in the morning with a stabbing pain that yanked me straight out of sleep. Third doctor, on a friend's recommendation, and I walked in with real hope. He said the same thing. Stress. Here's something I learned during those months: “it's stress” is often what you hear when nobody can figure out what's actually wrong. Everyone has stress. The explanation fits well enough to close the file. It isn't malicious — it's just the easiest place to land when the answer isn't obvious. But I was the one waking up in the dark, and I knew this wasn't in my head. The third time, I pushed back. Told him flatly that this wasn't stress, that something was really wrong. He paused, and to his credit, he didn't get defensive. He said, okay, let's do a CT scan and take a proper look. That one sentence was the hinge on which the next fifteen years of my life turned. The scan flagged something in my lower intestine. A GI specialist, a colonoscopy, a biopsy, and then that Tuesday phone call. Chronic disease, he explained. My immune system had decided my own digestive tract was the enemy and was attacking it, causing inflammation and pain when food passed through certain sections. There would be no cure. There would be management. Manageable, though, is still a word. The specialist was direct: take this seriously or you'll be looking at surgery down the road to remove damaged sections of intestine. He prescribed medication. He also told me, more importantly, that I'd need to change how I lived and what I ate. Here's the strange part about Crohn's — it's different for almost everyone who has it, and a lot of it comes down to food. One person's trigger is another person's breakfast. Someone can drink whiskey without a problem but end up doubled over from a glass of orange juice. In my case, the villains turned out to be alcohol, spicy food, orange juice, greasy fast food, and — the cruelest of them — coffee. I didn't discover this list overnight. It took roughly two years of paying close attention to my body, cutting things out, reintroducing them cautiously, and slowly assembling a map of what I could and couldn't handle. Losing coffee was harder than losing alcohol. I'm not proud of that, but it's true. A rough sketch of what those two years taught me: Around that time, I told a close friend what was going on. I was expecting the usual sympathy face. Instead he looked at me and said, “Dude, you're so lucky.” I nearly walked out of the room. How in any universe was I lucky to have a lifelong disease? He explained. The way he saw it, this thing was going to force me to eat well, pay attention to my body, and take my health seriously in a way most people never manage until it's too late. In his words, I'd probably end up healthier than most of our friends precisely because I had no choice in the matter. It didn't land at the time. I was too busy mourning coffee. But fifteen years on, I understand exactly what he meant. I cut those trigger foods completely — not most of the time, all of the time. I've had a long stretch now without a flare-up. And the discipline the disease demanded of me didn't stay in the kitchen. It bled into how I sleep, how I move, how I handle the inputs that shape a day. I'm not going to sit here and tell you a chronic illness is secretly wonderful. That's the kind of line people throw around in inspirational posts, and it always makes me wince. My friend's “you're lucky” was optimism, not medicine. Nobody handed me extra years. What I will say is this: the thing I was most afraid of ended up pushing me toward a healthier life than I would have built on my own initiative. Left to my own devices, I'd still be pouring my third cup of coffee at 2pm and telling myself I'd start eating better on Monday. The disease made Monday non-negotiable. A few lessons have stayed with me from all of this, and if you're in the middle of something similar, they might be worth something. First: trust your body and keep advocating for yourself. If something feels off and you keep getting brushed aside, don't stop asking. I heard “it's stress” three times before someone finally ordered the test that found the truth. Had I accepted the first answer, or the second, I'd still be in pain — or worse. You know your body better than anyone with a stethoscope who's met you for eleven minutes. You're allowed to keep pushing. Second: a hard diagnosis can be a strange kind of turning point. Not because the illness is good — it isn't — but because it forces the changes you've been putting off. It made me confront habits I would have happily coddled forever. Some people find that turning point through diagnosis. Others find it through the death of someone close, or through the collapse of a career, or through a plant-medicine ceremony that shakes them out of a decade of autopilot. The doorway looks different. The invitation is the same. Third: silver linings are usually invisible while you're standing in the storm. My friend saw mine long before I could. It took me a decade and a half to catch up to him. That's normal. You don't have to see the meaning right away. You just have to keep walking. Viktor Frankl wrote that when we can no longer change a situation, we're challenged to change ourselves. I've thought about that line a lot. Chronic illness is one version of that challenge. So is grief. So is addiction. So is the slow realization that the life you built no longer fits the person you've become. Some people find their way through with therapy. Some through faith. Some through community. And a growing number of people are finding their way through carefully held plant-medicine work — ayahuasca, psilocybin, ibogaine — as part of a bigger picture that includes better food, better sleep, better boundaries, and the kind of honest self-inquiry most of us avoid until forced. If any of that resonates, curated healing and plant-medicine retreats from around the world can be browsed on our marketplace here. You might not like the assignment life just handed you. Nobody does, in the moment. But there's a decent chance that a few years from now, if you actually take the assignment seriously, you'll look back and realize it was the thing that finally changed you for the better.
Craving More Stories?
Join our ShopAyahuascaRetreats newsletter for the latest updates on thrilling
destinations and inspirational tales, delivered straight to your inbox!
We value your privacy. Your email address will never be shared or published.
How Mindset Shapes Heart Health — And Why It Matters for Healing
Think back to the last time something threw you off — a health scare, a rough patch at work, a stretch where nothing landed right. Did some quiet part of you assume you'd come through okay? Or did you brace for a longer slide? That single reflex — the one that fires before you've even fully registered what happened — turns out to matter more than most of us realise. Not just for mood. For your heart, literally. And for whether the habits you've been trying to build actually stick. This is territory I keep circling back to when I talk with people preparing for a retreat or working through recovery. The mindset question isn't fluffy self-help. It's one of the more practical levers you have. Researchers have been chasing this thread for a couple of decades now, and the pattern is stubborn. People who tend to expect good outcomes develop less coronary heart disease over time and recover better after cardiac events. That pattern holds even after you strip out the obvious explanations — diet, exercise, smoking, sleep. Why? Nobody's found a single clean mechanism, and honestly, that's probably because there isn't one. Optimists tend to eat a little better, move a little more, and stay connected to other people because they put in the effort relationships require. Underneath the behaviour, there also seems to be something happening at the biological level — quieter inflammation, more balanced immune signalling, less of the low-grade stress response that grinds arteries down over years. None of these effects are dramatic on their own. But small advantages that stack across decades add up to real differences in outcomes. It's compound interest, applied to a nervous system. Here's the moment optimism actually earns its keep: right after something breaks the routine. A stressful week. A diagnosis. A day when the motivation just isn't there and the couch is winning. People with a more hopeful default tend to keep putting in effort exactly at that point. People bracing for the worst tend to disengage — not because they're weaker, but because the story they're telling themselves has already written the ending. Why bother finishing a book you've decided ends badly? It's less about grit and more about a small internal calculation: is the effort worth it? Over months, that calculation is often the difference between a habit that lasts and one that quietly evaporates. The genuinely encouraging bit — and this surprises people — is that optimism is trainable. It's not a fixed personality feature you're stuck with. One study using a short virtual reality biofeedback exercise shifted participants toward a more optimistic outlook in just one or two sessions. You don't need the tech. Noticing your own outlook in ordinary moments works the same mental muscle. Every heart-healthy habit — and every recovery practice, for that matter — will get interrupted. That's not a character flaw. It's arithmetic. You'll have a bad week. You'll travel. You'll get sick. You'll skip the walk, order takeout three nights running, blow off the morning practice. What separates people who regroup from people who abandon the whole project isn't willpower. It's what they say to themselves in the moment they realise they've slipped. The technical term here is self-compassion — treating your own setback with the same tone you'd use on a close friend who'd stumbled. Not indulgence. Not letting yourself off the hook. Just refusing to add a second, self-inflicted injury on top of the first one. People assume being kind to themselves after a setback makes them lazier. The research keeps finding the opposite. Self-compassionate people are more likely to see setbacks as information, more likely to try again, more likely to actually finish the thing they started. Self-criticism, by contrast, makes you want to disappear from the task entirely — which is why the diet you fell off in March is still not being followed in November. One program worth knowing about — the Compassionate and Loving Mindset (CALM Hearts) intervention — works with women at elevated cardiovascular risk. Participants learn their personal risk, set one specific goal, and then get taught self-compassion as a concrete skill they apply through short daily writing exercises. Nobody's told to think positively and push through. They're taught to notice the setback, meet it with the kindness they'd offer a friend, and get back to the goal. You don't need to be enrolled in a study to borrow the approach. A few things I've watched work in real life: None of this requires becoming a different person. It just asks for one slightly kinder response the next time something goes sideways. I keep noticing how much of this overlaps with what people describe after serious inner work — whether that's therapy, meditation, or ceremony with plant medicines. The common thread is that the harsh internal voice tends to get quieter, and something more patient takes its place. People come back from a well-held ayahuasca retreat, for instance, and one of the most consistent reports isn't about visions. It's about a softer relationship with their own mistakes. That softness is exactly the ingredient the cardiology research keeps pointing at. Not blind positivity. Not toxic cheerfulness. Just the ability to fall short and not treat it as evidence that you're finished. Which is why I think of mindset work and deeper healing practices as feeding the same fire. You don't need to pick one. A daily practice of noticing the story you're telling yourself is a good thing on its own — and it also happens to prepare the ground for anything more intensive you might explore later. For readers whose research is leading them further, curated plant-medicine and healing retreats can be browsed on our marketplace here. Your heart doesn't just respond to what you eat and how you move. It responds to the tone of your own inner voice, day after day, year after year. That tone is not fixed. You can practice a warmer one, in small ordinary moments, without doing anything dramatic. Try it once, the next time something doesn't go the way you wanted. See what happens. Then try it again the time after that. Not perfectly — that's not the point. Just a little kinder than last time.
What Positive Mental Health Actually Means for People Considering Plant Medicine
Most people who start looking into an ayahuasca retreat aren't chasing enlightenment. They're tired. Tired of the low-grade depression that never quite lifts, the drinking that started as fun and became a fixture, the trauma that keeps rerouting their lives in small ugly ways. They want to feel better — and they've noticed that “not depressed anymore” isn't quite the same thing as “alive.” That gap — between the absence of illness and the presence of something worth calling flourishing — is what researchers have been trying to pin down for decades. And a recent international consensus finally put some structure around it. If you're considering plant medicine or a psychedelic retreat, this framework is genuinely useful. It gives you a way to think about what you're actually hoping to move toward, not just what you're trying to escape. For most of the 20th century, psychiatry ran on a simple assumption: mental illness and mental health sit at opposite ends of one line. Reduce symptoms, and health improves. It's clean, it's intuitive, and it turns out to be wrong — or at least badly incomplete. Researchers like Corey Keyes reframed the whole thing as two separate continua. One tracks mental illness (present or absent). The other tracks positive mental health, running from languishing to flourishing. The important part: those two lines move independently. You can have zero clinical symptoms and still feel hollow — no purpose, no real connection, no vitality. You can also be actively wrestling with depression and still have deep relationships, meaningful work, and a functioning sense of self. Anyone who has sat across from someone freshly out of a ceremony knows this intuitively. The medicine may have knocked out a symptom cluster — the intrusive thoughts, the cravings, the numbness — but the person still has to build a life worth staying sober for. Symptom reduction is the floor. Flourishing is the actual project. In 2025, a research team ran a structured Delphi process — a rigorous method for building expert consensus — with 122 specialists across 11 disciplines. They built on an earlier review of 155 different measures of well-being, which had originally identified 410 overlapping dimensions and boiled those down to 21 candidate themes. After three rounds of expert rating and refinement, 19 dimensions cleared the 75% agreement threshold. What emerged is not a theory. It's a taxonomy — a classification system with shared language. That distinction matters. Instead of arguing about whether Ryff's model beats Diener's or Deci and Ryan's, researchers and clinicians now have a common vocabulary. And the framework is explicitly multidimensional: you're not supposed to max out every category. People flourish differently depending on values, culture, life stage, and circumstance. Six dimensions cleared the highest bar, above 90% expert agreement: The other 13 dimensions — things like resilience, vitality, self-esteem, sense of safety, engagement, personal growth — landed between 75% and 89% agreement. All of them count. None of them, on their own, is enough. Here's where the taxonomy gets practically interesting. In the final Delphi round, experts were asked whether each dimension functions more as a driver (something that produces flourishing) or an outcome (a result of it). Autonomy and a sense of safety leaned toward the driver side. Happiness and life satisfaction leaned toward the outcome side. That's not a semantic distinction — it changes what you should actually work on. Think about it this way: if you go into an ayahuasca ceremony hoping to “feel happier,” you're chasing an outcome. Outcomes don't respond well to being chased directly. What ayahuasca and other master plants often do — when the container is good and the integration is real — is nudge the drivers. People come out with a clearer sense of what they actually value (autonomy). They report feeling safer in their own bodies for the first time in years (sense of safety). They see their own story differently and can hold it without flinching (self-acceptance). The happiness, when it comes, tends to arrive as a byproduct. This is why the retreats that work bother with things like preparation calls, dieta protocols, one-on-one integration sessions, and follow-up months later. They're not selling you a peak experience. They're trying to shift the drivers so the outcomes have somewhere to grow. Before you book anything, it's worth sitting down honestly and asking which of these 19 dimensions feel thin in your life right now. Not which ones you'd like to brag about — which ones actually feel underfed. This is more useful than the vague “I want to heal” framing that most people arrive with. A few practical prompts: Whatever you find, bring it into your conversation with any retreat you're vetting. A serious facilitator will want to hear it. They'll ask about your history, your medications, your intentions, your support system back home. If they don't — if they're just taking your credit card and telling you the jungle will handle the rest — that's a red flag. The taxonomy is useful here too as a diagnostic: retreats that only talk about “bliss” and “transformation” are pitching an outcome. Retreats that talk about integration, community, values clarification, and long-term work are aimed at drivers. Ayahuasca, psilocybin, ibogaine, San Pedro — these medicines don't manufacture flourishing. What they seem to do, in the best cases, is dissolve some of the obstacles to it. The ruminative loop that kept you stuck. The addictive pattern that had colonized your evenings. The trauma memory you couldn't approach without shutting down. When those obstacles loosen, the underlying drivers — meaning, connection, autonomy — often have room to breathe again. But the medicine doesn't do the building. That part is yours, and it happens in the boring weeks and months after the ceremony ends. This is why people who treat a retreat as a one-shot fix are often disappointed six months later, while people who treat it as the opening move in a longer game tend to see actual change. The taxonomy gives you a map for that longer game. You know what you're trying to grow. You know it's more than one thing. You know some pieces will come first and others will follow. For readers who want to take this further, a range of curated plant-medicine and psychedelic retreats can be browsed on our marketplace here — worth exploring alongside your own honest inventory of which dimensions of flourishing you're actually trying to build.
Harvard's $11M Ibogaine Study for Opioid Addiction: What It Actually Means
Something quietly significant just happened in the world of psychedelics and addiction research. Harvard-affiliated researchers landed roughly $11 million in federal funding to move ibogaine — the notoriously intense West African root medicine — toward its first properly sanctioned clinical trial in the United States. If you've been watching this space for a while, you know how big that sentence is. For decades, ibogaine has lived in a strange purgatory. People credit it with breaking heroin and fentanyl addictions in a single session. Others have died from it. It's legal in Mexico, illegal in the US, and quietly changing lives in clinics from Tijuana to Costa Rica. Now the National Institute on Drug Abuse — a federal agency, not a fringe advocacy group — is writing an eight-figure check to study it. That's worth paying attention to. The award is what researchers call a UG3/UH3 grant, capped at around $11 million, with an initial $2.3 million released to get things moving. The principal investigator is Joji Suzuki, a psychiatrist at Mass General Brigham and associate professor at Harvard Medical School whose lab has been poking at the edges of addiction medicine for a while now — GLP-1 drugs, psychedelics, the whole toolkit that mainstream psychiatry has largely ignored until recently. The plan unfolds in three stages. First: secure Investigational New Drug (IND) clearance from the FDA — the piece of paper that legally permits researchers to give ibogaine to human volunteers on American soil. Second: run a Phase I safety trial. Third: if the safety data looks acceptable, proceed to a Phase IIa study in people with opioid use disorder. Each stage depends on the previous one going smoothly, which in FDA-land is never a given. To put the IND question in perspective: only one ibogaine-adjacent compound has ever gotten that green light in the US, and it's noribogaine, the drug's primary metabolite, cleared earlier this year for a company called DemeRx to study at lower doses. Ibogaine itself — the full, intense molecule that people fly to Mexico for — has never been approved for a US clinical trial. If Harvard pulls it off, that's a first. If you've never read the ibogaine literature, here's the short version of why serious researchers keep coming back to it. In the underground and clinical-tourism world, ibogaine has a reputation for something no other treatment offers: interrupting opioid dependence in a single session, often with minimal withdrawal afterward. Not a taper. Not a months-long medication regimen. One long, grueling day inside your own head. People who've been through it describe a dreamlike waking state that lasts eight to twelve hours, an unflinching review of their own life choices, and — for many — a kind of neurological reset. When they wake up, the craving is gone or dramatically reduced. That's the anecdotal claim. It's been repeated by enough people, in enough places, for enough years, that scientists have stopped rolling their eyes and started asking the harder question: how? The current opioid crisis makes that question urgent. Fentanyl has broken most existing treatment models. Methadone and buprenorphine work for some people and not others. Deaths keep climbing. When a federal funding body starts writing checks for a Schedule I substance with a scary side-effect profile, it's a signal that the establishment has run out of ideas it likes better. Let's be honest about the risks, because pretending otherwise does no one any favors. Ibogaine can cause cardiac arrhythmias, specifically QT interval prolongation, and there have been deaths — mostly in unmonitored settings, often in people with undiagnosed heart conditions or other drugs in their system. Any legitimate ibogaine provider does extensive cardiac screening beforehand: ECGs, blood work, medical history. The clinics that skip this are the ones you read about in the sad news stories. Part of what the Harvard trial has to establish is a safety protocol that satisfies the FDA. That means figuring out dosing, monitoring, exclusion criteria, and rescue procedures with a rigor that underground clinics — even excellent ones — simply don't operate under. This is one of the genuine benefits of formal research: not that it validates what practitioners already know, but that it produces data solid enough to change insurance coverage, medical training, and eventually access. If you've landed on this article because you or someone you love is struggling with opioids — or alcohol, stimulants, or any of the other patterns ibogaine has been used to interrupt — here's my honest take. Federally funded research at Harvard is fantastic news for the long game. It'll probably take five to ten years before ibogaine is available as an approved treatment in a US clinic, if it ever gets there. That's a long time when you're using now. In the meantime, people are still going abroad. Reputable ibogaine clinics do exist — mostly in Mexico, Costa Rica, Portugal, and a few other jurisdictions where the legal picture allows it. The difference between a good one and a dangerous one comes down to medical staff on site, real cardiac screening, honest informed consent about risks, and — critically — an integration and aftercare plan. If a clinic promises you'll be cured in a weekend and never crave again, walk away. That's not how it works, even when it works. The other reality worth naming: ibogaine is one tool among several in the psychedelic-assisted recovery conversation. Ayahuasca has a long track record for helping people unwind patterns of substance use, particularly in traditional Amazonian settings and in centers like Takiwasi in Peru that specifically treat addiction with plant medicines. Psilocybin research at Johns Hopkins and NYU has shown real promise for alcohol and tobacco dependence. Different medicines suit different people and different problems. My suggestion, if you're reading this as someone weighing plant medicine for your own healing: don't wait for the FDA to bless something before you take your situation seriously. Also don't rush toward a Mexican clinic next week because you read a Harvard press release. What the Harvard grant tells us is that the direction of travel is real — the science is catching up to what people in the underground and traditional practitioners have been saying for a long time. The right move is usually the slow one. Learn as much as you can. Talk to people who've actually done it, not just the enthusiasts on Reddit — find the ones who've been three years out and can tell you what the year after their ceremony was actually like. Look into whether ayahuasca, psilocybin, or ibogaine (or something more traditional like therapy plus buprenorphine) fits your specific situation. Understand your own medical picture. And plan for the integration work that comes after, because that's the part almost nobody talks about at the front end. The Harvard news is a marker in a much longer road. Plant medicines are moving from the shadows into the labs, and while the pace of formal science is glacial compared to the urgency people feel, the momentum is real. If exploring a supervised plant medicine experience feels like a genuine step for you rather than a Hail Mary, a range of vetted ibogaine, ayahuasca, and psilocybin retreats focused on addiction and recovery can be browsed on our marketplace here. Take your time with the decision — this is one of those choices that rewards patience.
Sitting With Difficult Emotions: A Somatic Practice for Healing and Recovery
There's a moment in most healing journeys — whether you're integrating an ayahuasca ceremony, working through early recovery from addiction, or just navigating an ordinary rough week — when a hard emotion shows up and your whole system wants to bolt. Grief. Shame. That sinking dread you can't quite name. The body clenches. The mind reaches for something, anything, to make it stop. Scrolling. Snacking. Another drink. A story about why you shouldn't be feeling this in the first place. Here's the strange thing plant medicine work teaches you fast: the resistance is usually louder than the emotion itself. What we call suffering is often the fight against feeling, not the feeling. And any decent facilitator, therapist, or recovery coach worth their salt will eventually tell you the same uncomfortable truth — the way out really is through. This is a practice for that. A somatic, compassion-based meditation you can return to anytime an emotion feels too big to sit with. It pairs well with post-ceremony integration, it works during the shakier stretches of addiction recovery, and it's useful on a Tuesday afternoon when you're just having a bad one. Mindfulness people have been saying this for a couple of thousand years, and now neuroscience is more or less catching up: what we resist tends to stick around. When you clamp down on an emotion, your nervous system reads that clampdown as more threat. Which produces more emotion. Which produces more clamping. You can see how the loop goes. People who've sat with ayahuasca, psilocybin, or ibogaine often describe the same lesson landing in a much less abstract way — the medicine will show you a difficult memory or feeling, and the second you try to push it away, it multiplies. The second you soften and let it be there, it moves. Master plants have a way of making the theory undeniable. The practice below is a scaled-down, sober version of that same principle. You don't need a ceremony to do it. You just need ten quiet minutes and the willingness to stop fighting yourself for a little while. A few practical notes. First, don't reach for the hardest thing in your life on your first attempt. If you're new to sitting with emotions, pick something mildly annoying — a conversation that irritated you, a low-grade worry. Save the big grief and the deep trauma for when you have support around you, ideally a therapist or a trained integration guide. Second, find a spot where you won't be interrupted. Phone off. Door closed. If lying down puts you to sleep, sit up. If sitting feels rigid, try leaning against a wall. Third — and this is the one people skip — give yourself permission to stop. This isn't an endurance test. If something comes up that feels too much, you can open your eyes, feel your feet on the floor, and come back another day. That's not failure. That's skill. Read through slowly. Pause between steps. Or record yourself reading it out loud and play it back — that works surprisingly well. If you've ever come home from an ayahuasca retreat, you know the medicine doesn't really end when the ceremony ends. The weeks after are where the actual work happens — the same emotions and memories that surfaced in ceremony often keep surfacing at home, and without a skill for meeting them, people either spiral or numb out. This kind of practice gives the emotions somewhere to land. The overlap with addiction recovery is even more direct. Most substance use, at its root, is a strategy for not feeling something. Alcohol, opiates, stimulants, compulsive behaviours — they're all pretty efficient at that job, at least short-term. Long-term, they cost you everything. Learning to be with difficult emotions instead of running from them isn't a nice-to-have in recovery. It's the whole game. This is one of the reasons psychedelic-assisted approaches to addiction — ibogaine for opiate dependency, ayahuasca and psilocybin for alcoholism and cocaine use, kambo as part of broader detox frameworks — tend to work best when paired with somatic and mindfulness practices afterwards. The medicine cracks something open. Practices like this one help you keep it open in a way that's usable. This isn't therapy. If you're working with severe trauma, complex PTSD, or the kind of grief that's swallowing your days, please do this alongside a real trauma-informed practitioner — not instead of one. Somatic practices can occasionally surface more than you're ready to hold alone, and that's a sign to bring in support, not to muscle through. Also: you may do this practice and feel nothing shift. That's not a failure. Some emotions need to be visited many times before they move. Some sensations are stored deep enough that a single sit isn't going to unlock them. The practice is a relationship you're building with your own inner life, and relationships take time. And if you're in the pre-ceremony period before a plant-medicine retreat, this is one of the more useful things you can be doing. Facilitators consistently say the people who arrive with some capacity to sit with discomfort have easier journeys. Not necessarily easier content — the medicine gives you what it gives you — but a better ability to be with it when it comes. For readers thinking about taking this deeper, a range of curated ayahuasca and plant-medicine retreats — many of them offering integration coaching and somatic support alongside ceremony — can be browsed on our marketplace here. Whatever you decide, the willingness to turn toward what hurts, gently and on your own terms, is where the healing actually starts.
Why Standard Therapy Fails Torture Survivors — And What Actually Helps Heal
A woman sits across from a therapist in a bright, tidy office somewhere in North America. She fled her country after months in a detention cell — interrogations, beatings, the kind of things you don't write down. By any external measure, she's safe now. The therapist is warm, credentialed, genuinely kind. They hand her a worksheet on cognitive distortions and ask her to rate her anxiety on a scale of one to ten. She doesn't come back for a second session. I've heard versions of this story so many times I've stopped counting. And what surfaces isn't anger at the therapist — it's a quiet grief for the field itself. Western mental health care wasn't built for her. Until we say that out loud, we'll keep losing people who already survived the unsurvivable, not to their trauma but to our own lack of imagination. Standard psychotherapy rests on a foundation most clinicians never even notice they're standing on. It assumes healing is an interior event — something that happens inside one person, in a private room, in fifty-minute increments. It assumes language is the natural medium for processing pain. It assumes emotions can be named, examined, and rewired through the right technique. It assumes safety is a feeling you cultivate. For a survivor of torture or state violence, nearly every one of those assumptions collapses on contact with reality. When a person has been systematically targeted by a government — imprisoned, interrogated, humiliated, sexually assaulted, subjected to mock executions, stripped of their humanity in a coordinated way — the wound isn't primarily psychological in the way our textbooks describe. It goes deeper. The perpetrator wasn't a person. It was a system. And in many cases, that system is still in power, still persecuting people the survivor loves, still shaping the world they now have to live in. A worksheet doesn't touch that. A breathing exercise doesn't touch that. And the failure isn't the clinician's — it's the model's. For most survivors of state violence, the deepest injury is the destruction of trust — in institutions, in strangers, in the basic idea that the world is safe. That wound starts back home, where the governments meant to protect them became the source of terror. But for some, the wound doesn't end when they escape. I've worked with people who survived the Islamic Republic of Iran, the Taliban, and other repressive regimes, believing that if they could just reach a democratic country, they'd finally be safe. They'd made it, they thought, to a place where rules meant something. And then some of them found themselves behind another locked door — in immigration detention, describing conditions that echoed the very tactics they'd fled. Prolonged isolation. Humiliation. Threats. Physical and psychological abuse. What makes that experience uniquely devastating isn't only the suffering. It's the betrayal on top of the betrayal. They expected cruelty from an authoritarian regime. They didn't expect it here. More than one person has asked me some version of the same question: If this can happen here, then where is safe? That second fracture can shatter whatever fragile trust remained, leaving them convinced that nowhere in the world is truly safe. When someone survives torture, they don't just feel anxious or depressed. They lose the ground beneath their feet — the sense that the world is orderly, that they matter, that life has meaning, that justice exists as anything more than a word. No cognitive reframe reaches that. This is where I want to speak carefully, because it matters for anyone considering plant medicine or contemplative practice for deep trauma. Trauma-sensitive mindfulness has genuinely helped some survivors — I've seen it. But in my clinical work with people who've survived torture and state violence, I generally avoid interventions that ask a person to turn attention inward on the body or sit in prolonged silence. Here's why. Many of the people I work with learned, through repeated violence, that paying attention to their body meant anticipating pain. The body isn't experienced as a home. It's a crime scene. Directing focus inward can trigger flashbacks, panic, dissociation, or a flood of physiological arousal that has nowhere to go. Long silence and stillness can feel uncomfortably close to solitary confinement or interrogation — the practice itself becomes the threat. This has real implications for the psychedelic-assisted therapy conversation too. Ayahuasca, psilocybin, ibogaine — all of them amplify interoception. They pull attention inside. For a survivor whose interior is a minefield, an unprepared plant-medicine ceremony can be catastrophic, not curative. Any facilitator working with this population needs to understand that. The frame has to be built first. The body has to become a possible home again before it becomes a portal. So what does work? Not a single technique, but a reordering of priorities. For survivors of state violence, healing begins not in a therapy room but in the slow, patient rebuilding of trust — in another human being, and then in a community. Peer support. Cultural spaces. Shared ritual. Being among people who won't inflict pain, long enough for the nervous system to start believing it. Every culture has its own frameworks for making meaning out of suffering. For my Iranian clients, the poetry of Hafez and Rumi carries a healing weight no DSM category can approximate. For my Afghan clients, communal prayer, collective mourning, the quiet authority of elder women — these aren't supplements to treatment. They are the treatment. My job as a clinician is to make room for them, not to compete with them. And then there's the single most undervalued skill in this work: the capacity to hear what happened and not look away. Not to analyze. Not to reframe. Not to hurry the person toward resilience or hope or a better narrative. Just to stay in the truth of what's being shared. That kind of sustained, unflinching witness is itself profoundly healing, because it's the exact opposite of what the perpetrators wanted. They wanted silence. They wanted the world to avert its eyes. When we don't, we become part of the survivor's resistance. Western therapy is built on the premise that speaking about suffering is healing. Talk it out. Name it to tame it. But for many of the survivors I work with — Iranians, Afghans, people from communities that don't have a cultural tradition of confessing psychological pain to a stranger — language itself is already a site of violence. They were interrogated. Their words were used against them, sometimes to hurt people they loved. They learned, in the most brutal way possible, that speaking carries risk. And then we invite them into a small room and ask them to speak. Beyond that, the vocabulary of Western mental health — PTSD, trauma, triggers, self-care — often doesn't translate. Not just linguistically, but conceptually. Many of my clients don't identify as traumatized. They identify as survivors. As resisters. As people who did what had to be done. Organizing their experience around a diagnosis can feel like yet another institution telling them who they are — one more form of erasure dressed up as help. If you work in plant medicine — or you're considering a retreat and you carry a history that goes beyond ordinary grief and stress — a few things are worth sitting with. The mental health field isn't malicious. Most clinicians who fall short with this population do so because they were never taught otherwise — their training was built for a different kind of suffering in a different kind of world. The same is true across a lot of the psychedelic space. We're all still learning what it means to hold someone whose wound was inflicted by a system rather than a person. For readers who want to explore this territory carefully, a range of trauma-aware plant-medicine and ayahuasca retreats can be browsed on our marketplace here — and the good ones will screen you honestly, tell you when the timing isn't right, and treat community as part of the medicine rather than an afterthought. People who have survived the unsurvivable aren't waiting to be saved. They're waiting to be believed. To have someone sit with them in what actually happened — not to fix it, not to reframe it, not to hurry them toward some prettier version of themselves — but to say, simply and clearly: What happened to you was real. I believe you. And there is still a future that belongs to you.
Dreaming of a Psychedelic Retreat?
We have the best deals and offers from thousands of organizers all over the world! Get them into your mailbox every week!
We value your privacy. Your email address will never be shared or published.
